BAF53A Recombinant Antibody, PE-Cy5 Conjugated
Product Specifications
Background
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology) . Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner.
Synonyms
ACTL6; ACTL6A; Arp4; ArpNbeta; BAF53; BAF53A; hArpN beta; INO80K.
Gene ID
86
Swiss Prot
O96019
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
BAF53A
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from human ACTL6A
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
86
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6096011-01 100 mg
5,6-Dichloropurine-1-b-D-ribofuanosyl-H-benzimidazole (DBR, 5,6-Dichlorobenzimidazole 1-b-D-ribofuranoside)
Ask
View Details